Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma
Karrie Mei-Yee Kiang(Queen Mary Hospital), Gkk Leung(University of Manchester)
Cited by 8
Related Papers
Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways
|Neuro-Oncology|2013|93
Vitamin D Enhances Hematoma Clearance and Neurologic Recovery in Intracerebral Hemorrhage
|Stroke|2022|58
Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells
|BioMed Research International|2019|43
Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
|Journal of Neuro-Oncology|2012|42
Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma
|Oncology Letters|2022|9